M
Medimaging Integrated Solution Inc
TWSE:6796
Medimaging Integrated Solution Inc
TWSE:6796
Price:
72.2
TWD
-2.17%
Market Closed
Market Cap:
NT$2.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
TW |
|
C
|
Chubu Steel Plate Co Ltd
TSE:5461
|
JP |
|
T
|
Tempur Sealy International Inc
NYSE:SGI
|
US |
|
C
|
China Daye Non-Ferrous Metals Mining Ltd
HKEX:661
|
HK |
|
Diageo PLC
LSE:DGE
|
UK |
|
S
|
Shree Global Tradefin Ltd
BSE:512463
|
IN |
|
PAR Technology Corp
NYSE:PAR
|
US |
|
Kaisa Prosperity Holdings Ltd
HKEX:2168
|
CN |
Income Statement
Earnings Waterfall
Medimaging Integrated Solution Inc
Medimaging Integrated Solution Inc
Income Statement
Medimaging Integrated Solution Inc
Medimaging Integrated Solution Inc
Currency: TWD
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
2
|
3
|
4
|
6
|
7
|
8
|
9
|
9
|
10
|
11
|
|
| Revenue |
516
N/A
|
637
+23%
|
502
-21%
|
511
+2%
|
538
+5%
|
539
+0%
|
537
0%
|
512
-5%
|
492
-4%
|
474
-4%
|
539
+14%
|
575
+7%
|
608
+6%
|
656
+8%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(251)
|
(311)
|
(248)
|
(246)
|
(249)
|
(234)
|
(229)
|
(229)
|
(235)
|
(252)
|
(305)
|
(317)
|
(343)
|
(374)
|
|
| Gross Profit |
265
N/A
|
326
+23%
|
254
-22%
|
265
+4%
|
289
+9%
|
305
+5%
|
308
+1%
|
283
-8%
|
256
-9%
|
221
-14%
|
234
+6%
|
258
+10%
|
264
+3%
|
282
+7%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(190)
|
(240)
|
(195)
|
(193)
|
(201)
|
(215)
|
(216)
|
(231)
|
(231)
|
(231)
|
(238)
|
(241)
|
(255)
|
(262)
|
|
| Selling, General & Administrative |
(69)
|
(85)
|
(69)
|
(71)
|
(76)
|
(84)
|
(88)
|
(95)
|
(96)
|
(97)
|
(97)
|
(97)
|
(101)
|
(109)
|
|
| Research & Development |
(121)
|
(155)
|
(126)
|
(122)
|
(124)
|
(129)
|
(125)
|
(133)
|
(133)
|
(131)
|
(138)
|
(140)
|
(150)
|
(148)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Operating Income |
74
N/A
|
86
+16%
|
60
-31%
|
72
+20%
|
88
+23%
|
90
+2%
|
92
+2%
|
52
-43%
|
25
-52%
|
(10)
N/A
|
(4)
+61%
|
18
N/A
|
10
-42%
|
22
+110%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
16
|
33
|
27
|
16
|
12
|
1
|
(1)
|
9
|
8
|
(4)
|
11
|
6
|
(31)
|
(17)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
6
|
8
|
10
|
13
|
|
| Pre-Tax Income |
91
N/A
|
120
+32%
|
87
-27%
|
89
+2%
|
101
+14%
|
93
-8%
|
93
+0%
|
64
-31%
|
36
-45%
|
(12)
N/A
|
12
N/A
|
30
+147%
|
(11)
N/A
|
18
N/A
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(19)
|
(25)
|
(17)
|
(20)
|
(20)
|
(18)
|
(19)
|
(13)
|
(11)
|
(3)
|
(7)
|
(13)
|
(3)
|
(8)
|
|
| Income from Continuing Operations |
72
|
95
|
70
|
69
|
81
|
75
|
74
|
51
|
25
|
(15)
|
6
|
17
|
(15)
|
10
|
|
| Net Income (Common) |
72
N/A
|
95
+32%
|
70
-26%
|
69
-2%
|
81
+18%
|
75
-8%
|
74
-1%
|
51
-31%
|
25
-51%
|
(15)
N/A
|
6
N/A
|
17
+200%
|
(15)
N/A
|
10
N/A
|
|
| EPS (Diluted) |
2.02
N/A
|
2.49
+23%
|
1.91
-23%
|
1.81
-5%
|
2.13
+18%
|
1.97
-8%
|
1.94
-2%
|
1.32
-32%
|
0.64
-52%
|
-0.38
N/A
|
0.14
N/A
|
0.44
+214%
|
-0.38
N/A
|
0.26
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
